The Therapeutic Goods
Administration has designated
Bevacizumab (Avastin) as an orphan
drug.
The concentrated injection from
Roche Products is listed for the
treatment of persistent, recurrent
Stage IV carcinoma of the cervix.
Orphan drugs are intended to
treat, prevent or diagnose a rare
disease.
For more information, CLICK
HERE.The above article was sent to subscribers in Pharmacy Daily's issue from 07 May 14 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 07 May 14
THE role and significance of community pharmacy in regional areas was a key focus of discussion for the Nationals leader David Littleproud during last week’s visit to Orana Mall Pharmacy as part of a regional tour.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.